Prosecution Insights
Prosecution Insights
Tech Center 1700 • Art Units: 1644 1646 1678 1783
This examiner grants 58% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17843247 | Cancer Neoepitopes | Non-Final OA | Nant Holdings IP, LLC |
| 16961026 | Fusion Protein Extensions | Final Rejection | NantBio, Inc. |
| 17168621 | USE OF TRYPTOPHAN DERIVATIVES AND L-METHIONINE FOR PROTEIN FORMULATION | Final Rejection | Genentech, Inc. |
| 17776131 | SYSTEMS AND METHODS FOR RAPID, SENSITIVE MULTIPLEX IMMUNOASSAYS | Final Rejection | The Regents of the University of Michigan |
| 18265661 | FEATURES FOR DETERMINING DUCTAL CARCINOMA IN SITU RECURRENCE AND PROGRESSION | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18025586 | IMMUNOHISTOCHEMISTRY (IHC) PROTOCOLS AND METHODS FOR DIAGNOSING AND TREATING CANCER | Non-Final OA | ELI LILLY AND COMPANY |
| 18180991 | SYSTEMS AND METHODS FOR PREDICTING GRAFT DYSFUNCTION WITH EXOSOME PROTEINS | Non-Final OA | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK |
| 16980128 | IMMUNO-EXOSOMES AND METHODS OF USE THEREOF | Final Rejection | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 18057519 | COMPOSITION FOR PREVENTING OR ALLEVIATING CELLULAR SENESCENCE | Final Rejection | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION |
| 17924748 | DETECTION METHOD OF TARGET MOLECULE IN SPECIMEN AND DETECTION KIT FOR TARGET MOLECULE | Final Rejection | Yokogawa Electric Corporation |
| 17199195 | CSF-1R ANTIBODY FORMULATION | Final Rejection | Hoffmann-La Roche Inc. |
| 17801469 | DETECTION METHOD OF CIRCULATING BMP10 (BONE MORPHOGENETIC PROTEIN 10) | Non-Final OA | Roche Diagnostics Operations, Inc. |
| 18369273 | BIOLOGICAL CONJUGATES HAVING AN PHOTOGENERATED ACIDIC OR BASIC RELEASABLE DETECTION MOIETY ON TOP OF BIOLOGICAL TISSUES | Non-Final OA | Miltenyi Biotec B.V. & Co. KG |
| 18024603 | CONJUGATES HAVING AN ENZYMMATICALLY RELEASABLE DETECTION MOIETY AND A BARCODE MOIETY | Non-Final OA | Miltenyi Biotec B.V. & Co. KG |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy